Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
Munyaradzi Dimairo,
Elizabeth Coates,
Philip Pallmann,
Susan Todd,
Steven A Julious,
Thomas Jaki,
James Wason,
Adrian P Mander,
Christopher J Weir,
Franz Koenig,
Marc K Walton,
Katie Biggs,
Jon Nicholl,
Toshimitsu Hamasaki,
Michael A Proschan,
John A Scott,
Yuki Ando,
Daniel Hind,
Douglas G Altman
Dec 17, 2018
BACKGROUND: Adequate reporting of adaptive designs (ADs) maximises their potential benefits in the conduct of clinical trials. Transparent reporting can help address some obstacles and concerns relating to the use of ADs....